Overview Quote
Stock Activity
| Day Low - High | 45.45 - 45.92 |
| 52wk Low - High | 30.25 - 47.45 |
| Previous Close | 45.66 |
| Avg. Volume | 1,881,800 |
| Industry | MED PRODUCTS |
| Market Cap | 13.00 B |
| Div - Yield | 1.00 - 2.18 |
| Beta | 0.85 |
| P/E (F1) | 12.41 |
| Current Year Est. | 3.69 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
184 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Company Description
St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.94 | 0.88 | 3.69 | 3.93 |
| Number of Estimates | 18 | 18 | 19 | 19 |
| Low Estimate | 0.92 | 0.84 | 3.60 | 3.75 |
| High Estimate | 0.95 | 0.90 | 3.73 | NA |
| Year Ago EPS | 0.88 | 0.83 | 3.48 | 3.69 |
| EPS Growth | 6.63% | 5.89% | 6.17% | 6.42% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ST JUDE MEDICAL | STJ | 45.87 | ![]() |
![]() |
| HAEMONETICS CP | HAE | 42.71 | ![]() |
![]() |
| ATRICURE INC | ATRC | 9.12 | ![]() |
![]() |
| BAXANO SURGICAL | BAXS | 2.28 | ![]() |
![]() |
| CARDICA INC | CRDC | 1.19 | ![]() |
![]() |
| ESSILOR INTL SA | ESLOY | 55.99 | ![]() |
![]() |
| INVIVO THERAPT | NVIV | 3.89 | ![]() |
![]() |
| PURE BIOSCIENCE | PURE | 0.41 | ![]() |
![]() |
| SHANDONG WEIGAO | SHWGF | 1.29 | ![]() |
![]() |
| ABAXIS INC | ABAX | 46.89 | ![]() |
![]() |
Sector:Medical>> Industry:MED PRODUCTS
Zacks Commentary
BSX Commences U.S. INTREPID Trial
Jun 18, 2013
FDA Nod for STJ's Ellipse & Assura
Jun 13, 2013
St. Jude Expands Neuro Offerings
Jun 10, 2013
GB Aims at Growth, Realigns Biz
Jun 07, 2013
STJ Begins U.S. Trial for EnligHTN
Jun 05, 2013
Medtronic Endovascular Biz in Focus
May 31, 2013
St. Jude Begins EnligHTNment Study
May 24, 2013
Medtronic Beats Earnings, Results Stronger
May 22, 2013
Financials
| EPS TTM | 3.55 |
| Sales | 5,503 |
| Net Income | 763 |
| Price/Earnings | 12.92 |
| Price/Book | 3.39 |
| Price/Cash Flow | 10.33 |
| Price/Sales | 2.39 |
News
Research and Markets Adds Report: St. Jude Medical, Inc. 2013 Market Share Analysis - Close-Up Media
Jun 18, 2013
Next Resistance Level for St Jude Medical (STJ) is $45.71 - Financial News Network Online - Pivot Alerts
Jun 17, 2013
Research and Markets: St. Jude Medical, Inc. 2013 Market Share Analysis Gives Comprehensive Coverage of the Latest Financial Deals Involving the Company and its Subsidiaries - Businesswire
Jun 17, 2013
St. Jude Medical, Inc. 2013 Market Share Analysis Gives Comprehensive Coverage of the Latest Financial Deals Involving the Company and its Subsidiaries - M2
Jun 17, 2013
Beat the Market With the Father`s Day Portfolio - TheMotleyFool
Jun 16, 2013
FDA Nod for STJ's Ellipse & Assura - Zacks.Com
Jun 14, 2013
St Jude Medical (STJ) Showing Bullish Technicals With Resistance At $46.01 - Freshbrewedmedia
Jun 14, 2013
St. Jude Medical Gets FDA Approval of High-Voltage Defibrillators with New Safety Features - Close-Up Media
Jun 14, 2013
Broker Recommendations
| Current ABR | 2.12 |
| ABR (Last Week) | 2.12 |
| # of recs in ABR | 25 |
| Average Target Price | 46.06 |
| Industry Rank by ABR | 184 out of 265 |
| Rank in Industry | 9 out of 73 |

